Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: Results of a phase I trial

AM Scott, FT Lee, W Hopkins, JS Cebon, JM Wheatley, ZQ Liu, FE Smyth, C Murone, S Sturrock, D MacGregor, N Hanai, K Inoue, M Yamasaki, MW Brechbiel, ID Davis, R Murphy, A Hannah, M Lim-Joon, T Chan, G Chong Show all